Clinical Trials
- Brain, Spinal Cord & Nervous System
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Ages18 years and older
- GenderBoth
- Date05/16/2022
- Brain, Spinal Cord & Nervous System
Immunologic Mechanisms in Neurological Diseases
- Ages18 years and older
- GenderBoth
- Date03/30/2016
- Brain, Spinal Cord & Nervous System
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
- Ages18 years and older
- GenderBoth
- Date02/16/2022
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Date04/01/2021
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth
- Date07/01/2020